Finally, during the last 12 years on "Mad Money," here is the most important lesson Jim Cramer has learned: "Teach more and pick less."
When Cramer started as the host of "Mad Money," he said the show was a stock-picker's paradise in a raging bull market.
But as the show evolved, Cramer realized viewers wanted to hear more about how to analyze stocks — dive deep into the underlying companies and technical data to understand why they move the way they do.
His bottom line: "It's been 12 years since we started this one-man show about business, and it's been quite a run. I could say it's because we've always been trying to find that bull market, but truth is that you are the real reason we keep doing this, and we intend to continue for many more years to come."
In Cramer's lightning round, the "Mad Money" pointed to two areas, technology and biotechnology, where investors shouldn't be too hasty:
CyberArk: "I still like Cyberark, but remember, because Cisco came in so aggressively in that group that's really hurt a lot of the stocks, and Check Point's really become my favorite, so let's be a little more careful and circumspect. I also like Proofpoint. They've been pretty good, but things have gotten tough in that area because of Cisco being so aggressive."
Seattle Genetics: "Boy, you know, we had them on a couple of years ago, and I am just shocked about how well it is doing. That said, it is doing so well up at $67 … I think it's run too much, so I want to be very careful. I'm going to have to say don't buy."